Metabolic self-destruction in critically ill patients: Origins, mechanisms and therapeutic principles

Nutrition

Volumn 30, Issue 3, 2014, Pages 261-267

  Hartl, Wolfgang H ^a   Jauch, Karl Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Adaptive response; Auto cannibalism; Carbohydrate metabolism; Evolution; Focus eradication; Gut microbiome; Hyperglycemia; Phylogenesis; Protein metabolism; Severe sepsis; Shock; Trauma

Indexed keywords

ADAPTIVE RESPONSE; AUTO-CANNIBALISM; CARBOHYDRATE METABOLISM; EVOLUTION; FOCUS ERADICATION; GUT MICROBIOME; HYPERGLYCEMIA; PHYLOGENESIS; PROTEIN METABOLISM; SEVERE SEPSIS; SHOCK; TRAUMA;

BLOOD GLUCOSE; CRITICAL ILLNESS; DIETARY CARBOHYDRATES; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC DISEASES; PROTEINS;

EID: 84894903369     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.07.019     Document Type: Review

References (93)

1. Waterlow J.C. The nature and significance of nutritional adaptation. Eur J Clin Nutr 1999, 53(Suppl 1):S2-S5.
2. Corathers S.D., Falciglia M. The role of hyperglycemia in acute illness: supporting evidence and its limitations. Nutrition 2011, 27:276-281.
3. Englesbe M.J., Patel S.P., He K., Lynch R.J., Schaubel D.E., Harbaugh C., et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010, 211:271-278.
4. Norman K., Pichard C., Lochs H., Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr 2008, 27:5-15.
5. Gruther W., Benesch T., Zorn C., Paternostro-Sluga T., Quittan M., Fialka-Moser V., et al. Muscle wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris muscle layer. J Rehabil Med 2008, 40:185-189.
6. Plank L.D., Hill G.L. Similarity of changes in body composition in intensive care patients following severe sepsis or major blunt injury. Ann N Y Acad Sci 2000, 904:592-602.
7. Cerra F.B., Siegel J.H., Coleman B., Border J.R., McMenamy R.R. Septic autocannibalism. A failure of exogenous nutritional support. Ann Surg 1980, 192:570-580.
8. Weil Z.M., Norman G.J., DeVries A.C., Nelson R.J. The injured nervous system: a Darwinian perspective. Prog Neurobiol 2008, 86:48-59.
9. Hardaway R.M. Wound shock: a history of its study and treatment by military surgeons. Mil Med 2004, 169:265-269.
10. Trunkey D.D. History and development of trauma care in the United States. Clin Orthop Relat Res 2000, 374:36-46.
11. Odero W., Khayesi M., Heda P.M. Road traffic injuries in Kenya: magnitude, causes and status of intervention. Inj Control Saf Promot 2003, 10:53-61.
12. Griffiths J., Waldmann C., Quinlan J. Sexual dysfunction in intensive care survivors. Br J Hosp Med (Lond) 2007, 68:470-473.
13. Holliday R. Evolution of human longevity, population pressure and the origins of warfare. Biogerontology 2005, 6:363-368.
14. Meindl R. Human populations before agriculture. The Cambridge encyclopedia of human evolution 1992, 406-410. Cambridge University Press, Cambridge. S. Jones, R. Martin, D. Pilbeam (Eds.).
15. Finch C.E. Evolution in health and medicine Sackler colloquium: evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc Natl Acad Sci U S A 2010, 107(Suppl 1):1718-1724.
16. Keppie N.J., Naylor J.M. A retrospective study of the diagnoses and survival of elk admitted to a large animal referral clinic. Can Vet J 2005, 46:325-330.
17. Scott M. Musculoskeletal injuries in nonracing quarter horses. Vet Clin North Am Equine Pract 2008, 24:133-152.
18. Ottaviani E., Franceschi C. The invertebrate phagocytic immunocyte: clues to a common evolution of immune and neuroendocrine systems. Immunol Today 1997, 18:169-174.
19. Scapigliati G. Models and evolution of inflammatory activities. Curr Pharm Des 2010, 16:4159.
20. Kaiser P., Rothwell L., Avery S., Balu S. Evolution of the interleukins. Dev Comp Immunol 2004, 28:375-394.
21. Ottaviani E. Evolution of immune-neuroendocrine integration from an ecological immunology perspective. Cell Tissue Res 2011, 344:213-215.
22. Denver R.J. Structural and functional evolution of vertebrate neuroendocrine stress systems. Ann N Y Acad Sci 2009, 1163:1-16.
23. Andersson U., Tracey K.J. Neural reflexes in inflammation and immunity. JExp Med 2012, 209:1057-1068.
24. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
25. Soeters M.R., Soeters P.B. The evolutionary benefit of insulin resistance. Clin Nutr 2012, 31:1002-1007.
26. Waterlow J.C. Protein-energy malnutrition: challenges and controversies. Proc Nutr Soc India 1991, 37:59-86.
27. Reeds P.J., Jahoor F. The amino acid requirements of disease. Clin Nutr 2001, 20(Suppl 1):15-22.
28. Marimuthu K., Murton A.J., Greenhaff P.L. Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans. J Appl Physiol 2011, 110:555-560.
29. Ferrando A.A., Wolfe R.R. Restoration of hormonal action and muscle protein. Crit Care Med 2007, 35(Suppl):S630-S634.
30. Fanzani A., Conraads V.M., Penna F., Martinet W. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle 2012, 3:163-179.
31. Li P., Yin Y.L., Li D., Kim S.W., Wu G. Amino acids and immune function. Br J Nutr 2007, 98:237-252.
32. Calder P.C., Dimitriadis G., Newsholme P. Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr Opin Clin Nutr Metab Care 2007, 10:531-540.
33. MacIver N.J., Jacobs S.R., Wieman H.L., Wofford J.A., Coloff J.L., Rathmell J.C. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008, 84:949-957.
34. Maggs D.G., Jacob R., Rife F., Lange R., Leone P., During M.J., et al. Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadriceps muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle. J Clin Invest 1995, 96:370-377.
35. Maclean D.A., Bangsbo J., Saltin B. Muscle interstitial glucose and lactate levels during dynamic exercise in humans determined by microdialysis. JAppl Physiol 1999, 87:1483-1490.
36. Ljungqvist O., Jansson E., Ware J. Effect of food deprivation on survival after hemorrhage in the rat. Circ Shock 1987, 22:251-260.
37. Mizock B.A. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001, 15:533-551.
38. Dungan K.M., Braithwaite S.S., Preiser J.C. Stress hyperglycaemia. Lancet 2009, 373:1798-1807.
39. Gerich J.E. Control of glycaemia. Baillieres Clin Endocrinol Metab 1993, 7:551-586.
40. McGuinness O.P. Defective glucose homeostasis during infection. Annu Rev Nutr 2005, 25:9-35.
41. Dahn M.S., Mitchell R.A., Lange M.P., Smith S., Jacobs L.A. Hepatic metabolic response to injury and sepsis. Surgery 1995, 117:520-530.
42. Wahren J., Ekberg K. Splanchnic regulation of glucose production. Annu Rev Nutr 2007, 27:329-345.
43. Long C.L., Nelson K.M. Nutritional requirements based on substrate fluxes in trauma. Nutr Res 1993, 13:1459-1478.
44. Mészáros K., Lang C.H., Bagby G.J., Spitzer J.J. Invivo glucose utilization by individual tissues during nonlethal hypermetabolic sepsis. FASEB J 1988, 2:3083-3086.
45. Spolarics Z., Schuler A., Bagby G.J., Lang C.H., Mészáros K., Spitzer J.J. Tumor necrosis factor increases invivo glucose uptake in hepatic nonparenchymal cells. J Leukoc Biol 1991, 49:309-312.
46. Fu C.Y., Wang Y.C., Wu S.C., Chen Y.F., Chen R.J., Hsieh C.H., et al. Higher glucose on admission is associated with need for angioembolization in stable pelvic fracture. Am J Emerg Med 2012, 30:26-31.
47. Heath D.F. Glucose, insulin and other plasma metabolites shortly after injury. J Accid Emerg Med 1994, 11:67-77.
48. Pomerantz W.J., Hashkes P.J., Succop P.A., Dowd M.D. Relationship between serum glucose and injury severity score in childhood trauma. J Pediatr Surg 1999, 34:1494-1498.
49. Nakamura M., Oda S., Sadahiro T., Watanabe E., Abe R., Nakada T.A., et al. Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients. Crit Care 2012, 16:R58.
50. Thorell A., Nygren J., Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999, 2:69-78.
51. Gletsu N., Lin E., Zhu J.L., Khaitan L., Ramshaw B.J., Farmer P.K., et al. Increased plasma interleukin 6 concentrations and exaggerated adipose tissue interleukin 6 content in severely obese patients after operative trauma. Surgery 2006, 140:50-57.
52. Long C.L., Schaffel N., Geiger J.W., Schiller W.R., Blakemore W.S. Metabolic response to injury and illness: estimating energy and protein needs from indirect calorimetry and nitrogen balance. JPEN 1979, 3:452-456.
53. Elwyn D.H. Protein metabolism and requirements in the critically ill patient. Crit Care Clin 1987, 3:57-69.
54. Wilmore D.W. Metabolic management of the critically ill 1977, 149. Plenum Press, New York.
55. Cuesta J.M., Singer M. The stress response and critical illness: a review. Crit Care Med 2012, 40:3283-3289.
56. Gentile L.F., Cuenca A.G., Efron P.A., Ang D., Bihorac A., McKinley B.A., et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012, 72:1491-1501.
57. Doig G.S., Simpson F., Finfer S., Delaney A., Davies A.R., Mitchell I., et al. Nutrition Guidelines Investigators of the ANZICS Clinical Trials Group. Effect of evidence-based feeding guidelines on mortality of critically ill adults: a cluster randomized controlled trial. JAMA 2008, 300:2731-2741.
58. Rice T.W., Mogan S., Hays M.A., Bernard G.R., Jensen G.L., Wheeler A.P. Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure. Crit Care Med 2011, 39:967-974.
59. Soguel L., Revelly J.P., Schaller M.D., Longchamp C., Berger M.M. Energy deficit and length of hospital stay can be reduced by a two-step quality improvement of nutrition therapy: the intensive care unit dietitian can make the difference. Crit Care Med 2012, 40:412-419.
60. Singer P., Anbar R., Cohen J., Shapiro H., Shalita-Chesner M., Lev S., et al. The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med 2011, 37:601-609.
61. Casaer M.P., Mesotten D., Hermans G., Wouters P.J., Schetz M., Meyfroidt G., et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365:506-517.
62. Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D., Dhingra V., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. NICE-SUGAR Study Investigators.
63. Wolfe R.R. Sepsis as a modulator of adaptation to low and high carbohydrate and low and high fat intakes. Eur J Clin Nutr 1999, 53(Suppl 1):S136-S142.
64. Chambrier C., Laville M., Rhzioual Berrada K., Odeon M., Boulétreau P., Beylot M. Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond) 2000, 99:321-328.
65. Larsson J., Lennmarken C., Mårtensson J., Sandstedt S., Vinnars E. Nitrogen requirements in severely injured patients. Br J Surg 1990, 77:413-416.
66. Ishibashi N., Plank L.D., Sando K., Hill G.L. Optimal protein requirements during the first 2 weeks after the onset of critical illness. Crit Care Med 1998, 26:1529-1535.
67. Shaw J.H., Wildbore M., Wolfe R.R. Whole body protein kinetics in severely septic patients. The response to glucose infusion and total parenteral nutrition. Ann Surg 1987, 205:288-294.
68. Rennie M.J. Anabolic resistance in critically ill patients. Crit Care Med 2009, 37(Suppl):S398-S399.
69. Jensen G.L., Mirtallo J., Compher C., Dhaliwal R., Forbes A., Grijalba R.F., et al. International Consensus Guideline Committee. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. JPEN J Parenter Enteral Nutr 2010, 34:156-159.
70. Schetz M., Casaer M.P., Van den Berghe G. Does artificial nutrition improve outcome of critical illness?. Crit Care 2013, 17:302.
71. Stroud M. Protein and the critically ill; do we know what to give?. Proc Nutr Soc 2007, 66:378-383.
72. Heidegger C.P., Berger M.M., Graf S., Zingg W., Darmon P., Costanza M.C., et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet 2013, 381:385-393.
73. Mirnezami R., Kinross J.M., Vorkas P.A., Goldin R., Holmes E., Nicholson J., et al. Implementation of molecular phenotyping approaches in the personalized surgical patient journey. Ann Surg 2012, 255:881-889.
74. Siegelaar S.E., Hermanides J., Oudemans-van Straaten H.M., van der Voort P.H., Bosman R.J., Zandstra D.F., et al. Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care 2010, 14:R224.
75. Hart D.W., Wolf S.E., Chinkes D.L., Beauford R.B., Mlcak R.P., Heggers J.P., et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma 2003, 54:755-761.
76. Rüttinger D., Kuppinger D., Hölzwimmer M., Zander S., Vilsmaier M., Küchenhoff H., et al. Acute prognosis of critically ill patients with secondary peritonitis: the impact of the number of surgical revisions, and of the duration of surgical therapy. Am J Surg 2012, 204:28-36.
77. Dalfino L., Giglio M.T., Puntillo F., Marucci M., Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and meta-analysis. Crit Care 2011, 15:R154.
78. Disseldorp L.M., Nieuwenhuis M.K., Van Baar M.E., Mouton U. Physical fitness in people after burn injury: a systematic review. Arch Phys Med Rehabil 2011, 92:1501-1510.
79. Carli F. Postoperative metabolic stress: interventional strategies. Minerva Anestesiol 2006, 72:413-418.
80. Deitch E.A. Gut-origin sepsis: evolution of a concept. Surgeon 2012, 10:350-356.
81. Nieves E., Tobón L.F., Ríos D.I., Isaza A., Ramírez M., Beltrán J.A., et al. Bacterial translocation in abdominal trauma and postoperative infections. J Trauma 2011, 71:1258-1261.
82. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
83. Kamada N., Chen G., Núñez G. A complex microworld in the gut: Harnessing pathogen-commensal relations. Nat Med 2012, 18:1190-1191.
84. Boyer A.F., Kollef M.H. Probiotics for ventilator-associated pneumonia: the need for a large, multicenter, randomized controlled trial. Chest 2013, 143:590-592.
85. Petrof E.O., Dhaliwal R., Manzanares W., Johnstone J., Cook D., Heyland D.K. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med 2012, 40:3290-3302.
86. Van der Meer J.W.M., Vandenbroucke-Grauls C.M.J.E. Resistance to selective decontamination: the jury is still out. Lancet Infect Dis 2013, 13:282-283.
87. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371:651-659.
88. Khoruts A., Sadowsky M.J. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol 2011, 4:4-7.
89. Van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415.
90. Petrof E.O., Gloor GB Vanner S.J., Weese S.J., Carter D., Daigneault M.C., et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: "RePOOPulating" the gut. Microbiome 2013, 1:3.
91. Bonetto A., Aydogdu T., Jin X., Zhang Z., Zhan R., Puzis L., et al. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab 2012, 303:E410-E421.
92. Kumar A., Bhatnagar S., Paul P.K. TWEAK and TRAF6 regulate skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care 2012, 15:233-239.
93. Bhatnagar S., Kumar A. The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Curr Mol Med 2012, 12:3-13.